doi: 10.1016/j.immuni.2023.06.002 19 ChenM.HuangW
Our prescribing doctors provide ongoing monitoring and side-effect advice throughout this period, ensuring the transition feels seamless and your long-term health remains the priority
Tesofensine affects neurotransmitter reuptake and shows promise for weight loss in trials ranging from 24 to 52 weeks
GLP-1 Receptor Activation Mimics natural hormone effects on appetite control Appetite Reduction Affects brain areas responsible for hunger and satiety Slowed Stomach Emptying Helps you feel fuller longer and eat smaller portions Physician-Supervised Board-certified doctor monitors your progress and adjusts dosing Comprehensive Approach Combines medication with diet, exercise, and lifestyle modifications Progressive Results Weight loss develops over weeks and months as medication takes effect Medical Monitoring Bi-monthly follow-ups track results and manage any side effects Multiple Options Can prescribe Semaglutide, Ozempic, Wegovy, Mounjaro, or Zepbound Questions about GLP-1 Weight Loss Semaglutide is a medication that mimics GLP-1, a hormone that regulates appetite and blood sugar
The combination is being researched for its complementary mechanisms of action
Suitability requirement: Patient should not be breastfeeding or pregnant
